Detalhe da pesquisa
1.
Pharmacological elevation of sphingosine-1-phosphate by S1P lyase inhibition accelerates bone regeneration after post-traumatic osteomyelitis.
J Cell Mol Med
; 27(23): 3786-3795, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37710406
2.
Sphingosine-1-Phosphate (S1P) Lyase Inhibition Aggravates Atherosclerosis and Induces Plaque Rupture in ApoE-/-Mice.
Int J Mol Sci
; 23(17)2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077004
3.
Regulation of ABCA1-mediated cholesterol efflux by sphingosine-1-phosphate signaling in macrophages.
J Lipid Res
; 60(3): 506-515, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30655318
4.
Hepatocyte nuclear factor 1A deficiency causes hemolytic anemia in mice by altering erythrocyte sphingolipid homeostasis.
Blood
; 130(25): 2786-2798, 2017 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29109103
5.
Hepatocyte Nuclear Factor 1A Is a Cell-Intrinsic Transcription Factor Required for B Cell Differentiation and Development in Mice.
J Immunol
; 196(4): 1655-65, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26800876
6.
Sphingosine-1-phosphate promotes osteogenesis by stimulating osteoblast growth and neovascularization in a vascular endothelial growth factor-dependent manner.
J Bone Miner Res
; 39(3): 357-372, 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38477738
7.
Sphingosine-1-phosphate improves outcome of no-reflow acute myocardial infarction via sphingosine-1-phosphate receptor 1.
ESC Heart Fail
; 10(1): 334-341, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36217778
8.
Sphingosine-1-phosphate suppresses GLUT activity through PP2A and counteracts hyperglycemia in diabetic red blood cells.
Nat Commun
; 14(1): 8329, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38097610
9.
Revealing concealed cardioprotection by platelet Mfsd2b-released S1P in human and murine myocardial infarction.
Nat Commun
; 14(1): 2404, 2023 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37100836
10.
Cellular mechanisms and recommended drug-based therapeutic options in diabetic cardiomyopathy.
Pharmacol Ther
; 228: 107920, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34171330
11.
Agonist-induced activation of the S1P receptor 2 constitutes a novel osteoanabolic therapy for the treatment of osteoporosis in mice.
Bone
; 125: 1-7, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31028959
12.
Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss.
Nat Med
; 24(5): 667-678, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29662200
13.
Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content: Correction by Sphingosine-1-Phosphate-Loading.
J Am Coll Cardiol
; 66(13): 1470-85, 2015 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26403344